DRMA 8-K: SEC filing
Dermata Therapeutics
Filed with the SEC on · accession 0001493152-26-052715
DRMA filed a 8-K (current report) with the SEC on Nov 17, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Dermata Therapeutics announced additional positive results and photos from a completed cosmetic clinical study of its Tome Foundational Treatment, a once-weekly skin renewal product, and reported over 1,000 orders since launch.
Key details
✦ Ask GOAX AI about this filing — what it means for DRMA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DRMA?
Click hereFrequently asked questions
What did DRMA file with the SEC on Nov 17, 2026?
DRMA filed a 8-K (SEC filing). Dermata Therapeutics announced additional positive results and photos from a completed cosmetic clinical study of its Tome Foundational Treatment, a once-weekly skin renewal product, and reported over 1,000 orders since launch.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other DRMA SEC filings
- 8-K · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 10, 2026
- SCHEDULE 13G · SEC filingNov 2, 2026
- 8-K · SEC filingOct 29, 2026
- 424B3 · Secondary offeringOct 21, 2026
- EFFECT · Shelf registrationOct 20, 2026
- S-3 · Shelf registrationOct 9, 2026
- 8-K · Material agreementAug 17, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
Get alerts when DRMA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days